Tivic Health Systems Inc
Tivic Health Systems, Inc., a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for use in the treatment of sinus pain, pressure, and congestion. The company sells its products through online retailers and commercial distributors, as well as its own website. Its lead product candidate is Entolimod, a late-stage TLR5 a… Read more
Tivic Health Systems Inc (TIVC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.357x
Based on the latest financial reports, Tivic Health Systems Inc (TIVC) has a cash flow conversion efficiency ratio of -0.357x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.00 Million) by net assets ($5.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tivic Health Systems Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Tivic Health Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tivic Health Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tivic Health Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Woomera Mining Ltd
AU:WML
|
-0.075x |
|
NEXT (NXG.SG)
STU:NXG
|
N/A |
|
Merafe
JSE:MRF
|
-0.033x |
|
Kim Hin Joo
KLSE:0210
|
0.157x |
|
3M Co.
LSE:0QNY
|
N/A |
|
5AP
STU:5AP
|
N/A |
|
IPSEN (I7G.SG)
STU:I7G
|
N/A |
|
Centogene N.V.
NASDAQ:CNTGF
|
N/A |
Annual Cash Flow Conversion Efficiency for Tivic Health Systems Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Tivic Health Systems Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.54 Million | $-5.72 Million | -2.258x | +5.01% |
| 2023-12-31 | $3.58 Million | $-8.51 Million | -2.377x | +3.24% |
| 2022-12-31 | $3.63 Million | $-8.92 Million | -2.457x | -481.07% |
| 2021-12-31 | $13.27 Million | $-5.61 Million | -0.423x | -116.44% |
| 2020-12-31 | $-1.18 Million | $-3.03 Million | 2.572x | +266.15% |
| 2019-12-31 | $2.37 Million | $-3.67 Million | -1.548x | -- |